DelveInsight’s Drug Hypersensitivity market report thoroughly explains the Drug Hypersensitivity historical and forecasted epidemiology and the Drug Hypersensitivity market trends in the 7MM. The Drug Hypersensitivity report also analyzes the current Drug Hypersensitivity treatment algorithms, market dynamics, and unmet medical needs.
Key Takeaways from the Drug Hypersensitivity Market Report
According to a study conducted in the United States by Doa et al. (2018), nonsteroidal anti-inflammatory drug (NSAID)-induced hypersensitivity reactions are classified as either cross-reactive or selective by the European Network on Drug Allergy (ENDA).
According to a study conducted in France by Landry et al. (2019), a total of 9250 patients were investigated, with 1819 testing positive for at least one drug.
Key players involved in improving the Drug Hypersensitivity treatment landscape include the University of Southern California and others.
Key pipeline Drug Hypersensitivity therapy includes Cyclosporine and others.
The investigators at the University of Southern California are undertaking an early Phase I trial to establish the efficacy of the two medicines (Cyclosporine vs. Steroids) with specific objectives in mind so that they can study the safety of these two therapies in DRES’s patients.
Request for the sample to know more @ Drug Hypersensitivity Market Research
Drug Hypersensitivity Overview
Drug Hypersensitivity is an immune-mediated reaction to a drug. Symptoms range from mild to severe and include rash, anaphylaxis, and serum sickness. Drug Hypersensitivity Reactions (DHR) are allergic, exaggerated pharmacologic, and pseudo allergic reactions to medications caused by an enhanced immunologic or inflammatory response.
Drug Hypersensitivity Epidemiology Segmentation
The Drug Hypersensitivity report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Total Number of Cases based on the Utilization of Various Classes of Drugs
Drug Hypersensitivity Total Number of Cases
Drug Hypersensitivity Treatment Landscape
Drug Hypersensitivity is primarily treated with drug discontinuation, supportive treatment (e.g., antihistamines, corticosteroids, epinephrine), and, in some cases, desensitization.
Drug Hypersensitivity Market Outlook
The market dynamics of Drug Hypersensitivity are expected to change as drug utilization of various drugs increases. Thus with the anticipated increase in patients, the Drug Hypersensitivity market will experience an upsurge.
Get a detailed analysis of the market @ Drug Hypersensitivity Market Analysis
Drug Hypersensitivity Pipeline Therapies and Key Companies
Cyclosporine: University of Southern California
Table of Contents
1.
Report Introduction
2.
Executive Summary of Drug Hypersensitivity
3.
Drug Hypersensitivity Market Share at a Glance
4.
Drug Hypersensitivity Disease Background and Overview
5.
Drug Hypersensitivity Patient Journey
6.
Drug Hypersensitivity Epidemiology and Patient Population
7.
Country Wise: Epidemiology of Drug Hypersensitivity
8.
Drug Hypersensitivity Current Treatment and Medical Practices
9.
Current Unmet Needs of Drug Hypersensitivity
10.
Market Size of Drug Hypersensitivity
11.
Region-Wise Market size of Drug Hypersensitivity
12.
Drug Hypersensitivity Market Drivers
13.
Drug Hypersensitivity Market Barriers
14.
SWOT Analysis
15.
Drug Hypersensitivity Reimbursement and Market Access
16.
KOL Views
17.
Appendix
18.
Report Methodology
19.
DelveInsight Capabilities
20.
Disclaimer
21.
About DelveInsight
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Antibody Drug Conjugate Market
DelveInsight’s “Antibody Drug Conjugate- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Antibody Drug Conjugate, historical and forecasted epidemiology, as well as the Antibody Drug Conjugate market trends in the 7MM.
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Sandeep JoshiEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/